Home » Topics » Regulatory » Patents

Patents
RSS

Substance P and bradykinin antagonists from Kyowa Hakko

April 25, 1997

Allergan claims prostaglandin derivatives with vasodilating activity

April 25, 1997

Neurotrophic/neuroprotective agents described by Synthelabo

April 25, 1997

Yamasa describes cognition-enhancing agents

April 24, 1997

Potent, orally active ACAT inhibitors from Sankyo

April 24, 1997

Signal describes agents that block transcription factor activation

April 24, 1997

Arzneimittelwerk describes new anticonvulsants

April 24, 1997

Endothelin antagonists disclosed by BASF

April 24, 1997

WF-10917: new immunosuppressant from Fujisawa

April 24, 1997

Merck KGaA describes PDE IV inhibitors

April 24, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...